Empresa aTyr Pharma Inc Nasdaq
Acciones
US0021201035
Biotecnología e investigación médica
Resumen de negocios
Ventas por actividad
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Innovative Medicines
100,0
%
| 10 | 100,0 % | 0 | 100,0 % | -96,60 % |
Ventas por región
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 10 | 100,0 % | 0 | 100,0 % | -96,60 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Sanjay Shukla
CEO | Chief Executive Officer | 52 | 30/03/16 |
Jill Broadfoot
DFI | Director of Finance/CFO | 63 | 30/07/18 |
Lisa Carey
CTO | Chief Tech/Sci/R&D Officer | - | 01/06/15 |
Ashlee Dunston
IRC | Investor Relations Contact | - | 01/04/20 |
Peter Villiger
PRN | Corporate Officer/Principal | - | 01/05/16 |
Human Resources Officer | - | 24/12/21 | |
General Counsel | - | 06/10/21 | |
Leslie Nangle
PRN | Corporate Officer/Principal | - | - |
Nancy Krueger
LAW | General Counsel | 56 | 01/10/14 |
Andrew B. Cubitt
PRN | Corporate Officer/Principal | - | 01/09/11 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Paul Schimmel
FOU | Founder | 83 | 08/09/05 |
Tim Coughlin
CHM | Chairman | 57 | 10/04/17 |
John Clarke
BRD | Director/Board Member | 70 | 01/09/05 |
Sara Zaknoen
BRD | Director/Board Member | 65 | 25/05/21 |
Sanjay Shukla
CEO | Chief Executive Officer | 52 | 30/03/16 |
Jane Gross
BRD | Director/Board Member | 67 | 28/06/19 |
Svetlana Lucas
BRD | Director/Board Member | 52 | 28/06/19 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 69 010 940 | 67 228 938 ( 97,42 %) | 0 | 97,42 % |
Información de la empresa
aTyr Pharma, Inc.
10240 Sorrento Valley Road Suite 300
92121, San Diego
+858 731 8389
http://www.atyrpharma.comSector
Varia. 1 de ene. | Capi. | |
---|---|---|
+29,93 % | 48,16 mil M | |
-0,66 % | 41,73 mil M | |
+43,62 % | 41,03 mil M | |
-5,31 % | 28,77 mil M | |
+10,04 % | 25,59 mil M | |
-22,49 % | 18,96 mil M | |
+9,31 % | 12,92 mil M | |
+28,69 % | 12,03 mil M | |
-2,31 % | 11,77 mil M |